Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study

被引:11
作者
Bernard, Laurence [1 ]
Boucher, Julia [2 ,4 ]
Helpman, Limor [1 ,3 ]
机构
[1] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada
[2] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada
[3] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[4] Univ Ottawa, Dept Obstet Gynecol & Newborn Care, Ottawa Hosp, Ottawa, ON, Canada
关键词
Surgery; Cytoreductive; Ovarian; Bowelresection; Outcomes; SURGICAL SITE INFECTION; NEOADJUVANT CHEMOTHERAPY; ANTIMICROBIAL PROPHYLAXIS; ENHANCED RECOVERY; RECTOSIGMOID RESECTION; PRIMARY ANASTOMOSIS; COLORECTAL SURGERY; DEBULKING SURGERY; RISK-FACTORS; CANCER;
D O I
10.1016/j.ygyno.2020.06.504
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. Bowel procedures are commonly performed as part of ovarian cancer cytoreduction. The aim of this study was to assess the postoperative complication rates among women with an ovarian malignancy under going bowel resection/repair at the time of cytoreductive surgery compared with a control group (cytoreductive surgery without bowel resection or repair). Methods. Analysis of 4965 cytoreductive surgeries for suspected ovarian malignancies recorded in the American College of Surgeons' National Surgical Quality Improvement Program (NSQIP) datasets (2006-2017) was performed. One-way ANOVA, Kruskal-Wallis H and Chi-squared tests were used to evaluate and compare baseline characteristics between the groups and controls. Postoperative surgical site infection rates and other 30-day post-operative outcomes were assessed with multivariable logistic and linear regressions. Results. 8.3% (413/4965) of cytoreductive procedures had an associated repair of enterotomy (small or large bowel), 10.9% (541/4947) had an associated colectomy with primary anastomosis, and 2.1% (104/4965) had an associated colectomy with colostomy. Surgical site infections (SSI, either superficial incisional, deep incisional, organ space or wound dehiscence) were significantly more prevalent in the bowel resection/repair group (16.9% vs 5.7%, p < 0.0001). The odds of surgical infections were 2.67 times higher in patients who underwent a bowel resection or repair after controlling for age, BMI, ASA status, pre-operative weight loss, hypoalbuminemia, NSQIP morbidity score, length and complexity of surgical procedure. Conclusion. Patients undergoing bowel resection/repair at the time of cytoreductive surgery are at increased risk of surgical site infections, without increased risk of 30-day mortality. Interventions to mitigate the risk of infectious complications in these patients should be evaluated in a prospective fashion. (c) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:597 / 602
页数:6
相关论文
共 43 条
[1]  
Aimaq R, 2011, AM SURGEON, V77, P1290
[2]   Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Gostout, BS ;
Jones, MB ;
Stanhope, CR ;
Wilson, TO ;
Podratz, KC ;
Cliby, WA .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85
[3]   Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery [J].
Bratzler, Dale W. ;
Dellinger, E. Patchen ;
Olsen, Keith M. ;
Perl, Trish M. ;
Auwaerter, Paul G. ;
Bolon, Maureen K. ;
Fish, Douglas N. ;
Napolitano, Lena M. ;
Sawyer, Robert G. ;
Slain, Douglas ;
Steinberg, James P. ;
Weinstein, Robert A. .
SURGICAL INFECTIONS, 2013, 14 (01) :73-156
[4]   The role of bowel surgery with cytoreduction for epithelial ovarian cancer [J].
Cai, H. -B. ;
Zhou, Y. -F. ;
Chen, H. -Z. ;
Hou, H. -Y. .
CLINICAL ONCOLOGY, 2007, 19 (10) :757-762
[5]   Association of Open Approach vs Laparoscopic Approach With Risk of Surgical Site Infection After Colon Surgery [J].
Caroff, Daniel A. ;
Chan, Christina ;
Kleinman, Ken ;
Calderwood, Michael S. ;
Wolf, Robert ;
Wick, Elizabeth C. ;
Platt, Richard ;
Huang, Susan .
JAMA NETWORK OPEN, 2019, 2 (10) :E1913570
[6]  
Chen M, 2016, DIS COLON RECTUM, V59, P70, DOI 10.1097/DCR.0000000000000524
[7]   What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? [J].
Chi, D. S. ;
Eisenhauer, E. L. ;
Lang, J. ;
Huh, J. ;
Haddad, L. ;
Abu-Rustum, N. R. ;
Sonoda, Y. ;
Levine, D. A. ;
Hensley, M. ;
Barakat, R. R. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :559-564
[8]   Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome [J].
Fagotti, Anna ;
Ferrandina, Gabriella ;
Vizzielli, Giuseppe ;
Fanfani, Francesco ;
Gallotta, Valerio ;
Chiantera, Vito ;
Costantini, Barbara ;
Margariti, Pasquale Alessandro ;
Alletti, Salvatore Gueli ;
Cosentino, Francesco ;
Tortorella, Lucia ;
Scambia, Giovanni .
EUROPEAN JOURNAL OF CANCER, 2016, 59 :22-33
[9]  
Fleetwood VA, 2016, AM SURGEON, V82, P302
[10]   Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis [J].
Fournier, M. ;
Huchon, C. ;
Ngo, C. ;
Bensaid, C. ;
Bats, A. S. ;
Combe, P. ;
le FrereBelda, M. A. ;
Fournier, L. ;
Berger, A. ;
Lecuru, F. .
EJSO, 2018, 44 (06) :750-753